Moreover, Machado et al. demonstrated that minocycline inhibits enzymatic activity of gelatin proteases activated by ischemia after experimental stroke and is likely to be selective for MMP-9 at low doses [47]. This evidence concerns the gene MMP9 and stroke disorder.